105 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
26 Nov 18
Current report (foreign)
4:20pm
of such breach and insists on the ongoing validity of the respective obligations on both parties pursuant to the agreement. No litigation … of the affected technology. If the Company becomes involved in patent litigation, it could consume a substantial portion of its resources.
- 19
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Mar 19
51-102F3 Material Change Report
4:53pm
regarding the status of the agreement between Shiseido and the Company remains unresolved but is not the subject of any litigation or arbitration … unresolved but is not the subject of any litigation or arbitration. RepliCel maintains the Agreement remains intact and is communicating with Shiseido
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
on the ongoing validity of the respective obligations on both parties pursuant to the agreement. No litigation or the triggering of other dispute … in patent litigation, it could consume a substantial portion of its resources.
The Company may be subject to changes and uncertainties in laws
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
to the agreement. No litigation or the triggering of other dispute mechanisms has been entered into by either party and RepliCel management is actively … in patent litigation, it could consume a substantial portion of its resources.
The Company may be subject to changes and uncertainties in laws
6-K
EX-99.2
t18wcget
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
pemq8
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
5t9inf njyr
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
zrshvo 00fct
7 Oct 14
RepliCel Life Sciences Adds Industry Specialist to Management Team
12:00am
6-K
0asu r2j24l
3 Aug 04
Current report (foreign)
12:00am
6-K
EX-99.2
cnjqh
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
6ugqxscatq1nk8y2uru7
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
n7xf akse566m7
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
2mjd8fcfam4ppu
10 Sep 04
Current report (foreign)
12:00am
6-K
nt6 yiith62o
1 Jun 06
Current report (foreign)
12:00am
6-K
EX-99.2
b2jxk6drronw1ame7y
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
mve4umzj1cdme
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
1h93tg1nr qi7
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.1
arpcw0y
25 Oct 17
Current report (foreign)
12:00am
6-K
o5vmzb
8 Oct 04
Current report (foreign)
12:00am